Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difluprednate in Anterior Uveitis
NCT00406887Phase 3Completed
- Sponsor
- Sirion Therapeutics, Inc.
- Start
- Aug 2002
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of difluprednate in anterior uveitis (AU) and panuveitis (2 arms), sponsored by Sirion Therapeutics, Inc. Primary endpoint: Change from baseline in anterior chamber cell score at 14 days. Started Aug 2002; status: completed.
02
Drugs
difluprednate
03
Conditions
anterior uveitis (AU)panuveitis
Beyond the preview
Go deeper on NCT00406887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406887.